UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer

Cancer science, 2017-11, Vol.108 (11), p.2176-2186

2017

Volltextzugriff (PDF)

MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1

Bioscience reports, 2018-10, Vol.38 (5)

2018

Volltextzugriff (PDF)

Lipocalin 2 potentially contributes to tumorigenesis from colitis via IL-6/STAT3/NF-κB signaling pathway

Bioscience reports, 2022-05, Vol.42 (5), p.1

2022

Volltextzugriff (PDF)

Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation

Molecular cancer research, 2017-02, Vol.15 (2), p.141-151

2017

Volltextzugriff (PDF)

HDAC inhibitor SB939 potentiates TRAIL-induced apoptosis in colorectal cancer cells

Cellular and Molecular Biology, 2023-05, Vol.69 (5), p.12-18

2023

Volltextzugriff (PDF)

Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer

International journal of oncology, 2018-12, Vol.53 (6), p.2789-2799

2018

Volltextzugriff (PDF)

Anti-angiogenic and anti-tumor activity of Bavachinin by targeting hypoxia-inducible factor-1α

European journal of pharmacology, 2012-09, Vol.691 (1-3), p.28-37

2012

Volltextzugriff (PDF)

SPION-loaded chitosan–linoleic acid nanoparticles to target hepatocytes

International journal of pharmaceutics, 2009-04, Vol.371 (1), p.163-169

2009

Volltextzugriff (PDF)

Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer

Cancer letters, 2013-07, Vol.335 (2), p.479-486

2013

Volltextzugriff (PDF)

Superparamagnetic iron oxide nanoparticles-loaded chitosan-linoleic acid nanoparticles as an effective hepatocyte-targeted gene delivery system

International journal of pharmaceutics, 2009-05, Vol.372 (1), p.169-176

2009

Volltextzugriff (PDF)

Folate receptor targeted imaging using poly (ethylene glycol)-folate: in vitro and in vivo studies

Journal of Korean Medical Science, 2007, 22(3), , pp.405-411

2007

Volltextzugriff (PDF)

Parthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells

Intestinal research, 2017, 15(2), , pp.174-181

2017

Volltextzugriff (PDF)

Parthenolide enhances sensitivity of colorectal cancer cells to TRAIL by inducing death receptor 5 and promotes TRAIL-induced apoptosis

International journal of oncology, 2015-03, Vol.46 (3), p.1121-1130

2015

Volltextzugriff (PDF)

Parthenolide suppresses tumor growth in a xenograft model of colorectal cancer cells by inducing mitochondrial dysfunction and apoptosis

International journal of oncology, 2012-10, Vol.41 (4), p.1547-1553

2012

Volltextzugriff (PDF)

Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells

Intestinal research, 2015-07, Vol.13 (3), p.233-241

2015

Volltextzugriff (PDF)

Acquired Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Resistance of Human Colorectal Cancer Cells Is Linked to Histone Acetylation and Is Synergistically Ameliorated by Combination with HDAC Inhibitors

Digestive diseases and sciences, 2024-08

2024

Volltextzugriff (PDF)

Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer

International journal of oncology, 2017-12, Vol.51 (6), p.1809-1820

2017

Volltextzugriff (PDF)

Lipocalin 2 activates the NLRP3 inflammasome via LPS‑induced NF‑κB signaling and plays a role as a pro‑inflammatory regulator in murine macrophages

Molecular medicine reports, 2022-12, Vol.26 (6), Article 358

2022

Volltextzugriff (PDF)

The effect of PPAR-gamma agonist on (18)F-FDG uptake in tumor and macrophages and tumor cells

Nuclear medicine and biology, 2009-05, Vol.36 (4), p.427-433

2009

Volltextzugriff (PDF)

Parthenolide Sensitizes Human Colorectal Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand through Mitochondrial and Caspase Dependent Pathway

Intestinal research, 2014, 12(1), , pp.34-41

2014

Volltextzugriff (PDF)

Lipocalin 2 activates the NLRP3 inflammasome via LPS-induced NF-[kappa]B signaling and plays a role as a pro-inflammatory regulator in murine macrophages

Molecular medicine reports, 2022-12, Vol.26 (6)

2022

Volltextzugriff (PDF)

A novel HDAC1 inhibitor, CBUD‑1001, exerts anticancer effects by modulating the apoptosis and EMT of colorectal cancer cells

International journal of oncology, 2020-10, Vol.57 (4), p.1027-1038

2020

Volltextzugriff (PDF)

The HDAC1 Inhibitor CBUD-1001 Enhances TRAIL-induced Apoptosis in Colorectal Cancer Cells

Anticancer research, 2021-09, Vol.41 (9), p.4353-4364

2021

Volltextzugriff (PDF)

CORRIGENDUM

International journal of oncology, 2019-05, Vol.54 (5), p.1897

2019

Volltextzugriff (PDF)

Preproghrelin Leu72Met polymorphism in obese Korean children

Journal of pediatric endocrinology & metabolism : JPEM, 2005-11, Vol.18 (11), p.1083

2005

Volltextzugriff (PDF)

1 – 25 von 2.870

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.545)
Mit Volltextzugriff
(2.746)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(36)
... seit 30 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer

MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1

Lipocalin 2 potentially contributes to tumorigenesis from colitis via IL-6/STAT3/NF-κB signaling pathway

Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation

HDAC inhibitor SB939 potentiates TRAIL-induced apoptosis in colorectal cancer cells

Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer

Anti-angiogenic and anti-tumor activity of Bavachinin by targeting hypoxia-inducible factor-1α

SPION-loaded chitosan–linoleic acid nanoparticles to target hepatocytes

Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer

Superparamagnetic iron oxide nanoparticles-loaded chitosan-linoleic acid nanoparticles as an effective hepatocyte-targeted gene delivery system

Folate receptor targeted imaging using poly (ethylene glycol)-folate: in vitro and in vivo studies

Parthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells

Parthenolide enhances sensitivity of colorectal cancer cells to TRAIL by inducing death receptor 5 and promotes TRAIL-induced apoptosis

Parthenolide suppresses tumor growth in a xenograft model of colorectal cancer cells by inducing mitochondrial dysfunction and apoptosis

Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells

Acquired Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Resistance of Human Colorectal Cancer Cells Is Linked to Histone Acetylation and Is Synergistically Ameliorated by Combination with HDAC Inhibitors

Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer

Lipocalin 2 activates the NLRP3 inflammasome via LPS‑induced NF‑κB signaling and plays a role as a pro‑inflammatory regulator in murine macrophages

The effect of PPAR-gamma agonist on (18)F-FDG uptake in tumor and macrophages and tumor cells

Parthenolide Sensitizes Human Colorectal Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand through Mitochondrial and Caspase Dependent Pathway

Lipocalin 2 activates the NLRP3 inflammasome via LPS-induced NF-[kappa]B signaling and plays a role as a pro-inflammatory regulator in murine macrophages

A novel HDAC1 inhibitor, CBUD‑1001, exerts anticancer effects by modulating the apoptosis and EMT of colorectal cancer cells

The HDAC1 Inhibitor CBUD-1001 Enhances TRAIL-induced Apoptosis in Colorectal Cancer Cells

CORRIGENDUM

Preproghrelin Leu72Met polymorphism in obese Korean children

Suchergebnisse filtern